SOURCE: PropThink

August 28, 2013 09:10 ET

PropThink to Host Special Conference Call With Sunshine Heart CEO

Investors Are Invited to Dial-In and Participate in an Exclusive Conference Call With Sunshine Heart CEO David Rosa; Free Registration on Is Required to Join

NEW YORK, NY--(Marketwired - Aug 28, 2013) - ("PropThink"), a leading healthcare-focused provider of investment research and analysis, will host an interview and investor Q&A conference call with David Rosa, Chief Executive Officer at Sunshine Heart, Inc. (NASDAQ: SSH), on Tuesday, September 3rd, 2013 at 3:00 PM EDT.

The call is open to all investors who complete a free registration on Further instructions are available by visiting or by clicking here.

Why We're Interviewing Sunshine Heart

Shares of Sunshine Heart have appreciated significantly in the past four months, up over 140% since the company's mid-April capital raise, as healthcare investors have taken particular note of this small-cap medical device developer. Sunshine Heart's developmental C-Pulse Heart Assist device offers a novel approach to the treatment of late-stage congestive heart failure, and an early feasibility study completed in 2011 demonstrated that the device provided a strong benefit in a historically difficult-to-treat patient population. Heart failure patients in the early study have seen the severity of their disease improve drastically with time on the device, so much so in fact, that C-Pulse is arguably reversing the latter stages of congestive heart failure -- two of 20 patients have already been weaned from the product, and Sunshine Heart is evaluating more patients for complete removal of the implanted heart assist system. Now, a large pivotal trial being run in the United States and a second, smaller trial running concurrently in Europe are designed to bring the device through the approval process, and subsequently, to the thousands of patients suffering from late-stage heart failure in the U.S. and Europe.

How To Participate

1. Investors interested in participating in this PropThink-hosted event will need to register by visiting or by clicking here. Registration is open to all investors free of charge.

2. Registrants will receive a confirmation email with dial-in instruction 24 hours prior to the conference call. Participating investors will have the ability to ask Sunshine Heart's Chief Executive David Rosa questions following the interview portion of the call -- the operator will provide instructions on how to jump in queue for questions during the call.

Questions about the conference call can be directed to

About PropThink

PropThink is an intelligence service that delivers long and short trading ideas to investors in the healthcare and life sciences sectors. Our focus is on identifying and analyzing technically complicated companies and equities that are grossly over- or under-valued. We offer daily market coverage, weekly feature stories, and a newsletter to investors who subscribe on To learn more, follow us on Twitter or visit us at In addition, PropThink is offering investors 30 days of free access to a premium intelligence service designed to empower individual investors by providing actionable, timely, and accurate research on companies and investment opportunities in the healthcare sector.